First Mercantile Trust’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$148K Sell
3,070
-8
-0.3% -$370 0.02% 528
2021
Q2
$139K Buy
3,078
+273
+10% +$12.1K 0.02% 574
2021
Q1
$135K Buy
2,805
+1,153
+70% +$60K 0.02% 579
2020
Q4
$89K Buy
+1,652
New +$74.7K 0.01% 716
2017
Q4
Sell
-22,463
Closed -$250K 824
2017
Q3
$250K Buy
+22,463
New +$219K 0.05% 505

Other funds holding NEO

First Mercantile Trust's NEO Position: Q3 2021 in Review

First Mercantile Trust reduced its NeoGenomics (NEO) stake by 0.26% in Q3 2021, selling an estimated $370 and leaving 3,070 shares worth $148K. The position accounts for 0.02% of the portfolio, ranked #528.

First Mercantile Trust first reported a position in NEO in Q3 2017 and has held it in 5 quarters since. The position peaked at $250K in Q3 2017. 324 funds tracked by Wall St. Rank hold NEO as of Q3 2021.

  • First Mercantile Trust held 3,070 shares of NeoGenomics worth $148K as of Q3 2021.
  • First Mercantile Trust sold 8 NeoGenomics shares in Q3 2021, an estimated $370.
  • NeoGenomics made up 0.02% of First Mercantile Trust's portfolio in Q3 2021, its #528 holding.
  • First Mercantile Trust first reported a position in NeoGenomics in Q3 2017 and has held it in 5 quarters since.
  • First Mercantile Trust's NeoGenomics position peaked at $250K in Q3 2017.
  • 324 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.